An ophthalmologist explains why screen time can cause digital eye strain, dry eyes, headaches and neck tension — and how ...
Verywell Health on MSN

How dry eye syndrome is diagnosed

Medically reviewed by Andrew Greenberg, MD Key Takeaways Tests for dry eye syndrome can help confirm a diagnosis and assess its severity.Most dry eye syndrome tests are simple and done in-office.A ...
Verywell Health on MSN

Dry eye syndrome causes

Medically reviewed by Andrew Greenberg, MD Key Takeaways Dry eye syndrome can have many causes, including aging, prolonged screen use, allergies, environmental conditions, contact lenses, and problems ...
An investigational eye drop relieves symptoms of dry eye disease as early as week 1 in a pooled analysis of two trials, with ...
A2Z Eyecare's Waldwick practice now offers dry eye disease and meibomian gland dysfunction evaluation and treatment for ...
Frequent dry eyes may signal more than simple irritation and could be an early warning sign of an autoimmune disease. This symptom has long been associated with Sjögren's Disease, a chronic autoimmune ...
Treating dry eye disease with both Xiidra and Miebo led to significant improvements in signs and symptoms, with most patients ...
Patients with dry eye disease who used Tryptyr reported significantly improved quality of life in addition to reduced dry eye ...
A panelist discusses how dry eye disease involves tear film imbalance, leading to inflammation and ocular surface damage, emphasizing the importance of precise diagnosis and tailored treatment while ...
Most people don't spend much time thinking about their eyes until there's a problem — and then it's hard to think of anything else. Dry eye disease is one of those issues that's hard to ignore, ...
Vancouver, Jan. 10, 2024 (GLOBE NEWSWIRE) -- The global dry eye syndrome market size was USD 5.32 billion in 2022 and is expected to register a revenue CAGR of 7.3% during the forecast period.
Aldeyra Therapeutics, Inc. plans to submit a Formal Dispute Resolution Request (FDRR) to the FDA for reproxalap, its investigational drug candidate for dry eye disease. The request appeals the March ...